#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15186	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2081	722.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1460	1460	C	897	C,T,A	857,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27532	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3287	822.1	0	.	n	.	0	T695C	SNP	695	695	T	793	793	C	835	C,T	791,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27532	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3287	822.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1435	1435	A	894	A,G	834,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27532	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3287	822.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2069	2069	C	832	C	783	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27532	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3287	822.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2695	2695	T	853	T,C	811,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27532	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3287	822.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2143	2143	A	934	A	895	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	V36A	NONSYN	106	108	GTG	461	463	GCG	201;201;199	G;C;G	189;191;191	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	503	505	CGG	190;186;185	C;G;G	181;175;174	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	S68L	NONSYN	202	204	TCG	557	559	TTG	183;182;182	T;T,C;G	171;172,1;173	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	A90V	NONSYN	268	270	GCG	623	625	GTT	174;172;171	G;T;T	168;158;161	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	I105V	NONSYN	313	315	ATT	668	670	GTT	161;161;160	G;T;T	153;148;151	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	N125T	NONSYN	373	375	AAT	728	730	ACC	181;180;178	A;C;C	163;165;165	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	R135C	NONSYN	403	405	CGT	758	760	TGT	182;185;183	T;G;T	163;169;167	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	K151E	NONSYN	451	453	AAA	806	808	GAA	162;161;160	G;A;A	153;151;151	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	809	811	AAC	163;162;164	A;A;C	151;150;155	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	A172T	NONSYN	514	516	GCG	869	871	ACA	144;144;144	A;C;A	136;138;139	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	A175E	NONSYN	523	525	GCG	878	880	GAA	147;153;153	G;A;A	141;147;147	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	E176T	NONSYN	526	528	GAA	881	883	ACC	153;154;156	A;C;C	135;148;149	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	I178V	NONSYN	532	534	ATC	887	889	GTC	157;159;158	G;T;C	150;151;152	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	I188T	NONSYN	562	564	ATA	917	919	ACG	166;165;170	A;C;G	153;154;158	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	P200N	NONSYN	598	600	CCC	953	955	AAC	171;173;172	A;A;C	163;163;162	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1013	1015	TTG	165;169;167	T;T;G	155;159;156	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1070	1072	ACC	148;148;149	A,G;C;C,G	137,1;140;138,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1073	1075	GAC	148;149;148	G;A;C	139;137;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1082	1084	GCG	149;145;142	G;C,A;G	140;112,1;133	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1118	1120	GCT	136;137;137	G,T;C;T,C	121,1;121;119,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1740	folP	858	858	91.61	folP.l15.c4.ctg.1	1518	114.3	1	SNP	p	R230S	1	.	.	688	690	AGC	1043	1045	AGC	179;176;178	A;G;C	172;167;166	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5804	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3438	168.4	1	SNP	p	S91F	0	.	.	271	273	TCC	664	666	TCC	233;232;230	T;C;C	218;218;213	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5804	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3438	168.4	1	SNP	p	D95N	0	.	.	283	285	GAC	676	678	GAC	221;222;219	G;A;C	204;205;204	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5804	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3438	168.4	1	SNP	p	D95G	0	.	.	283	285	GAC	676	678	GAC	221;222;219	G;A;C	204;205;204	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1688	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1490	113.1	1	SNP	p	G45D	1	.	.	133	135	GAC	536	538	GAC	189;192;193	G;A;C	179;183;188	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	880	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1078	81.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5434	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3119	173.7	1	SNP	p	D86N	0	.	.	256	258	GAC	629	631	GAC	239;241;244	G;A;C	227;227;234	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5434	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3119	173.7	1	SNP	p	S87I	0	.	.	259	261	AGT	632	634	AGT	244;245;246	A;G;T	233;233;233	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5434	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3119	173.7	1	SNP	p	S87W	0	.	.	259	261	AGT	632	634	AGT	244;245;246	A;G;T	233;233;233	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5434	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3119	173.7	1	SNP	p	S87R	0	.	.	259	261	AGT	632	634	AGT	244;245;246	A;G;T	233;233;233	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5434	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3119	173.7	1	SNP	p	S88P	0	.	.	262	264	TCC	635	637	TCC	244;240;244	T;C;C	231;228;233	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4304	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2527	169.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1433	1435	GGC	206;200;198	G;G;C	197;191;187	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1256	1258	GCA	225;228;228	G;C;A	207;209;215	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1259	1261	ATC	228;226;231	A;T;C,A	214;212;218,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1271	1273	GTG	226;226;226	G;T;G	210;210;212	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1271	1273	GTG	226;226;226	G;T;G	210;210;212	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1775	1777	ACC	191;194;196	A;C;C	180;183;186	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1829	1831	GCG	172;173;177	G;C;G	152;135;147	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1829	1831	GCG	172;173;177	G;C;G	152;135;147	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1952	1954	GGC	169;165;165	G;G;C	155;149;152	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1961	1963	GGC	162;159;160	G;G;C	146;145;147	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	161.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1979	1981	CCG	134;134;130	C,G;C;G,C	109,4;108;103,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6092	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3154	192.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2558	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1818	139.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	495	495	C	179	C	169	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	G38E	NONSYN	112	114	GGA	492	494	GAA	241;242;239	G;A;A	225;225;223	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	S46D	NONSYN	136	138	AGC	516	518	GAC	201;200;200	G;A,G;C	194;191,1;193	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	522	524	GGA	209;210;213	G;G;A	196;197;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	T87A	NONSYN	259	261	ACT	639	641	GCT	200;204;201	G;C;T	184;188;180	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	645	647	AGC	203;204;205	A;G;C	188;187;186	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	737	738	CG	196;196	C;G	187;186	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	740	742	CAG	193;196;196	C;A;G	187;188;190	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	744	746	AAA	198;196;195	A;A;A	191;190;189	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	807	809	GAA	214;214;217	G;A;A	196;194;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	831	833	GCA	233;231;229	G,A;C;A	212,1;212;210	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1023	1025	ACT	205;206;203	A;C;T	192;191;189	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1032	1034	ATG	201;201;202	A;T,C;G	187;190,1;188	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1146	1148	GCA	204;206;207	G;C;A	189;190;192	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1149	1151	ACG	208;207;204	A;C;G	191;191;190	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1152	1154	GGG	204;202;202	G;G;G	190;186;187	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1155	1157	GTT	201;199;202	G;T;T	185;184;187	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1215	1217	GTA	230;225;225	G;T,G;A	207;206,1;211	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1254	1256	ACT	218;217;219	A;C;T	200;204;205	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1260	1262	GAT	217;218;217	G;A;T	202;202;202	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1272	1274	CAC	213;211;210	C;A;C	197;194;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	1	SNP	p	G120K	1	.	.	358	360	AAG	737	739	CGG	196;196;196	C;G;G	187;186;186	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	1	SNP	p	A121D	1	.	.	361	363	GAC	740	743	CGC	193;196;195	C;G;C	187;190;188	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2692	porB1b	1047	1047	96.95	porB1b.l15.c4.ctg.1	1566	170.9	1	SNP	p	D121N	0	.	.	361	363	GAC	740	743	CGC	193;196;195	C;G;C	187;190;188	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10316	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4897	210.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2031	2033	CAT	250;250;252	C;A;T	238;238;237	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1094	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1149	94.7	1	SNP	p	V57M	1	.	.	169	171	ATG	566	568	ATG	222;224;225	A;T;G	213;214;215	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
